| 1978N-0065 | Skin Bleaching Drug Products | |||||||||||||||||||||||
| FDA Comment Number : | EC290 | |||||||||||||||||||||||
| Submitter : | Mrs. R. Williams | Date & Time: | 12/21/2006 09:12:42 | |||||||||||||||||||||
| Organization : | Mrs. R. Williams | |||||||||||||||||||||||
| Category : | Individual Consumer | |||||||||||||||||||||||
| Issue Areas/Comments | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| I began using Obagi products with doctor supervision and I have been satisfied with the results. Consumers of this type of product should be able to purchase these products from sources that have provided them in the past and should remain on the market. However, if the FDA is aware of reasons that this product should not be on the market, then the public should be notified immediately and massive information should be distributed. | ||||||||||||||||||||||||